NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

人獸通用感染疾病治療的全球市場:各疾病類型,各類藥物的市場調查,預測(∼2025年),COVID-19的累積性的影響

Zoonotic Disease Treatment Market Research Report by Disease Type, by Drug Class, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 1005053
出版日期 內容資訊 英文 181 Pages
商品交期: 最快1-2個工作天內
價格
人獸通用感染疾病治療的全球市場:各疾病類型,各類藥物的市場調查,預測(∼2025年),COVID-19的累積性的影響 Zoonotic Disease Treatment Market Research Report by Disease Type, by Drug Class, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 181 Pages
簡介

全球人獸通用感染疾病治療的市場規模預測將從2020年的351億2,217萬美元,擴大到2025年前的436億632萬美元增長。

COVID-19是前所未有的全球性公共衛生突發事件,已影響到每個行業。這種長期影響預計將在預測期內影響行業增長。我們正在進行的研究正在擴大我們的研究範圍,以確保我們窮究潛在的COVID-19問題和未來路徑。該報告考慮了消費者行為和需求的變化,購買方式,供應鏈的重新改道,當前市場趨勢以及政府的重要介入等因素,提供有關COVID-19的洞察,分析,與預測。

 

這份報告提供人獸通用感染疾病治療的世界市場調查,提供市場概要,市場成長要素及阻礙因素分析,市場機會,COVID-19的影響,病類型·藥物類別·各地區的市場規模的變化與預測,競爭情形,主要企業的簡介等系統性資訊。

目錄

第1章 序文

  • 調查的目的
  • 市場區隔和涵蓋範圍
  • 調查涵蓋年份
  • 貨幣和價格
  • 語言
  • 限制事項
  • 利害關係者

第2章 調查手法

  • 調查流程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:調查設備
    • 收集:資料來源
    • 分析:資料的解釋
    • 制定:資料檢驗
    • 公開:調查報告
    • 重複:報告的更新
  • 調查的實行
    • 開始:調查流程
    • 計劃:調查計劃的作成
    • 實行:調查的實施
    • 檢驗:發現與分析
    • 出版物:調查報告
  • 調查成果

第3章 摘要整理

  • 市場預測
  • 藥物類別預測
  • 病類型預測
  • 地區預測
  • 其他競爭公司預測

第4章 市場概要

  • COVID-19累積的影響

第5章 市場洞察

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • 波特的五力分析
    • 新加入廠商業者的威脅
    • 替代品的威脅
    • 客戶談判力
    • 供給企業談判力
    • 產業的競爭

第6章 各疾病類型

  • 狂犬病(恐水症)
  • 結核
  • 病毒性肝炎

第7章 各類藥物

  • 抗菌藥
  • 抗生素

第8章 南北美洲

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太地區

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第10章 歐洲,中東·非洲

  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第11章 競爭情形

  • FPNV定位矩陣
    • 象限
    • 事業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 市場佔有率分析
  • 其他競爭公司的SWOT分析
  • 競爭模式
    • 合併和收購
    • 契約,合作,及夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 獎,獎勵,擴大

第12章 企業的實用性簡介

  • AstraZeneca PLC
  • Bavarian Nordic A/S
  • BIO-MED
  • Cadila Healthcare Limited
  • CSC Pharmaceuticals International
  • CSL Limited
  • CureVac AG
  • Dr. Reddy's Laboratories Ltd
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline PLC
  • GlaxoSmithKline plc
  • Grifols, S.A
  • Informa PLC
  • Johnson & Johnson services, Inc
  • Kamada Ltd.
  • Kedrion Biopharma Inc
  • Merck & Co., Inc
  • Mylan N.V
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi S.A
  • Solvay S.A.
  • Synermore Biologics Co., Ltd.
  • Taj Pharmaceuticals Limited
  • VBI Vaccines

第13章 附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-0315DDADCE32

The Global Zoonotic Disease Treatment Market size was estimated at USD 35.12 Billion in 2020 and expected to reach USD 36.85 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 5.26% to reach USD 47.77 Billion by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Zoonotic Disease Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Disease Type, the Zoonotic Disease Treatment Market was studied across Rabies, Tuberculosis, and Viral Hepatitis.

Based on Drug Class, the Zoonotic Disease Treatment Market was studied across Antibacterial Medication and Antibiotics.

Based on Geography, the Zoonotic Disease Treatment Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Zoonotic Disease Treatment Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Zoonotic Disease Treatment Market, including AstraZeneca PLC, Bavarian Nordic A/S, BIO-MED, Cadila Healthcare Limited, CSC Pharmaceuticals International, CSL Limited, CureVac AG, Dr. Reddy's Laboratories Ltd, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, GlaxoSmithKline plc, Grifols, S.A, Informa PLC, Johnson & Johnson services, Inc, Kamada Ltd., Kedrion Biopharma Inc, Merck & Co., Inc, Mylan N.V, Novartis International AG, Pfizer Inc., Sanofi S.A, Solvay S.A., Synermore Biologics Co., Ltd., Taj Pharmaceuticals Limited, and VBI Vaccines.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Zoonotic Disease Treatment Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Zoonotic Disease Treatment Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Zoonotic Disease Treatment Market?
  • 4. What is the competitive strategic window for opportunities in the Global Zoonotic Disease Treatment Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Zoonotic Disease Treatment Market?
  • 6. What is the market share of the leading vendors in the Global Zoonotic Disease Treatment Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Zoonotic Disease Treatment Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Drug Class Outlook
  • 3.4. Disease Type Outlook
  • 3.5. Geography Outlook
  • 3.6. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing demand for animal proteins and consumption of animal fats
      • 5.1.1.2. Ongoing clinical trial by pharmaceuticals companies
      • 5.1.1.3. Increase in consumption of antibiotics
    • 5.1.2. Restraints
      • 5.1.2.1. Patent expiration of branded drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Novel drugs development
      • 5.1.3.2. Amalgamation strategies in the competitive landscape
    • 5.1.4. Challenges
      • 5.1.4.1. Absence of consciousness about zoonotic disease
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Zoonotic Disease Treatment Market, by Disease Type

  • 6.1. Introduction
  • 6.2. Rabies
  • 6.3. Tuberculosis
  • 6.4. Viral Hepatitis

7. Zoonotic Disease Treatment Market, by Drug Class

  • 7.1. Introduction
  • 7.2. Antibacterial Medication
  • 7.3. Antibiotics

8. Americas Zoonotic Disease Treatment Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States
    • 8.6.1. California
    • 8.6.2. Florida
    • 8.6.3. Illinois
    • 8.6.4. New York
    • 8.6.5. Ohio
    • 8.6.6. Pennsylvania
    • 8.6.7. Texas

9. Asia-Pacific Zoonotic Disease Treatment Market

  • 9.1. Introduction
  • 9.2. China
  • 9.3. India
  • 9.4. Indonesia
  • 9.5. Japan
  • 9.6. Malaysia
  • 9.7. Philippines
  • 9.8. South Korea
  • 9.9. Thailand

10. Europe, Middle East & Africa Zoonotic Disease Treatment Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Quadrant
  • 11.4. Market Share Analysis, By Company
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. AstraZeneca PLC
  • 12.2. Bavarian Nordic A/S
  • 12.3. BIO-MED
  • 12.4. Cadila Healthcare Limited
  • 12.5. CSC Pharmaceuticals International
  • 12.6. CSL Limited
  • 12.7. CureVac AG
  • 12.8. Dr. Reddy's Laboratories Ltd
  • 12.9. F. Hoffmann-La Roche AG
  • 12.10. GlaxoSmithKline PLC
  • 12.11. GlaxoSmithKline plc
  • 12.12. Grifols, S.A
  • 12.13. Informa PLC
  • 12.14. Johnson & Johnson services, Inc
  • 12.15. Kamada Ltd.
  • 12.16. Kedrion Biopharma Inc
  • 12.17. Merck & Co., Inc
  • 12.18. Mylan N.V
  • 12.19. Novartis International AG
  • 12.20. Pfizer Inc.
  • 12.21. Sanofi S.A
  • 12.22. Solvay S.A.
  • 12.23. Synermore Biologics Co., Ltd.
  • 12.24. Taj Pharmaceuticals Limited
  • 12.25. VBI Vaccines

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
  • 13.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, 2020 VS 2026 (USD BILLION)
  • FIGURE 2. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2020 (USD BILLION)
  • FIGURE 3. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2020 (USD BILLION)
  • FIGURE 4. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 (USD BILLION)
  • FIGURE 5. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET: MARKET DYNAMICS
  • FIGURE 6. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 7. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2020 VS 2026 (%)
  • FIGURE 8. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2020 VS 2026 (USD BILLION)
  • FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2026
  • FIGURE 10. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY RABIES, 2018-2026 (USD BILLION)
  • FIGURE 11. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY RABIES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 12. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TUBERCULOSIS, 2018-2026 (USD BILLION)
  • FIGURE 13. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TUBERCULOSIS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 14. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY VIRAL HEPATITIS, 2018-2026 (USD BILLION)
  • FIGURE 15. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY VIRAL HEPATITIS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 16. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2020 VS 2026 (%)
  • FIGURE 17. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2020 VS 2026 (USD BILLION)
  • FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2026
  • FIGURE 19. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ANTIBACTERIAL MEDICATION, 2018-2026 (USD BILLION)
  • FIGURE 20. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ANTIBACTERIAL MEDICATION, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 21. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2018-2026 (USD BILLION)
  • FIGURE 22. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 23. AMERICAS ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 24. AMERICAS ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 26. ARGENTINA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 27. BRAZIL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 28. CANADA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 29. MEXICO ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 30. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 31. CALIFORNIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 32. FLORIDA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 33. ILLINOIS ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 34. NEW YORK ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 35. OHIO ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 36. PENNSYLVANIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 37. TEXAS ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 38. ASIA-PACIFIC ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 39. ASIA-PACIFIC ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 41. CHINA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 42. INDIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 43. INDONESIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 44. JAPAN ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 45. MALAYSIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 46. PHILIPPINES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 47. SOUTH KOREA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 48. THAILAND ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 49. EUROPE, MIDDLE EAST & AFRICA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 50. EUROPE, MIDDLE EAST & AFRICA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 51. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 52. FRANCE ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 53. GERMANY ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 54. ITALY ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 55. NETHERLANDS ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 56. QATAR ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 57. RUSSIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 58. SAUDI ARABIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 59. SOUTH AFRICA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 60. SPAIN ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 61. UNITED ARAB EMIRATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 62. UNITED KINGDOM ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 63. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET: FPNV POSITIONING MATRIX
  • FIGURE 64. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 65. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 66. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ZOONOTIC DISEASE TREATMENT MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 4. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY RABIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 5. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TUBERCULOSIS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 6. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY VIRAL HEPATITIS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 7. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 8. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ANTIBACTERIAL MEDICATION, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 9. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 10. AMERICAS ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 11. AMERICAS ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 12. AMERICAS ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 13. ARGENTINA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 14. ARGENTINA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 15. BRAZIL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 16. BRAZIL ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 17. CANADA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 18. CANADA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 19. MEXICO ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 20. MEXICO ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 21. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 22. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 23. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 24. CALIFORNIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 25. CALIFORNIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 26. FLORIDA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 27. FLORIDA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 28. ILLINOIS ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 29. ILLINOIS ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 30. NEW YORK ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 31. NEW YORK ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 32. OHIO ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 33. OHIO ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 34. PENNSYLVANIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 35. PENNSYLVANIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 36. TEXAS ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 37. TEXAS ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 38. ASIA-PACIFIC ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 39. ASIA-PACIFIC ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 40. ASIA-PACIFIC ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 41. CHINA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 42. CHINA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 43. INDIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 44. INDIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 45. INDONESIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 46. INDONESIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 47. JAPAN ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 48. JAPAN ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 49. MALAYSIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 50. MALAYSIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 51. PHILIPPINES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 52. PHILIPPINES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 53. SOUTH KOREA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 54. SOUTH KOREA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 55. THAILAND ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 56. THAILAND ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 60. FRANCE ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 61. FRANCE ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 62. GERMANY ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 63. GERMANY ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 64. ITALY ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 65. ITALY ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 66. NETHERLANDS ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 67. NETHERLANDS ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 68. QATAR ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 69. QATAR ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 70. RUSSIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 71. RUSSIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 72. SAUDI ARABIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 73. SAUDI ARABIA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 74. SOUTH AFRICA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 75. SOUTH AFRICA ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 76. SPAIN ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 77. SPAIN ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 78. UNITED ARAB EMIRATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 79. UNITED ARAB EMIRATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 80. UNITED KINGDOM ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 81. UNITED KINGDOM ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 82. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET: SCORES
  • TABLE 83. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET: BUSINESS STRATEGY
  • TABLE 84. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET: PRODUCT SATISFACTION
  • TABLE 85. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET: RANKING
  • TABLE 86. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 87. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET: SHARE, BY COMPANY, 2020
  • TABLE 88. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET: MERGER & ACQUISITION
  • TABLE 89. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 90. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 91. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET: INVESTMENT & FUNDING
  • TABLE 92. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 93. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET: LICENSE & PRICING
  • TABLE 94. GLOBAL ZOONOTIC DISEASE TREATMENT MARKET: CONTACT DETAILS